Home World News EMA Recommends Extension of Therapeutic Indications for Ponatinib World News EMA Recommends Extension of Therapeutic Indications for Ponatinib By Ogkologos - February 27, 2026 390 0 Facebook Twitter Google+ Pinterest WhatsApp Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR How We’re Working to Help People With Cancer Across the World April 7, 2021 Some People with Rectal Cancer Can Skip Radiation Before Surgery July 19, 2023 ESMO Calls for Robust EU Taxation of Tobacco Products, Aiming to... September 18, 2025 Blinatumomab Increases Survival for Infants with an Aggressive Type of ALL June 8, 2023 Load more HOT NEWS FDA Approves Sirolimus Protein-Bound Particles for Malignant Perivascular Epithelioid Cell Tumour Cancer Research UK reports record levels of investment in its spinouts Good-bye, Old Friend GreaterGood’s Inaugural Breast Cancer Research Professor Is Changing the Face of...
